Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1547-1553

  Grangette, C ^a   Muller Alouf H ^a   Goudercourt, D ^a   Geoffroy, M C ^a   Turneer, M ^a   Mercenier, A ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOSTIMULATING AGENT; TETANUS TOXIN; TETANUS TOXIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; FEMALE; GENETIC RECOMBINATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LACTIC ACID BACTERIUM; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TETANUS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES; DRUG CARRIERS; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOBACILLUS; MICE; MICE, INBRED C57BL; NASAL MUCOSA; NEUTRALIZATION TESTS; TETANUS TOXIN; TETANUS TOXOID; VACCINATION; VACCINES, SYNTHETIC;

EID: 0035118294     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1547-1553.2001     Document Type: Article

References (36)

1. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus toxin vaccine
2. Animal models of pneumocystosis
3. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen
4. Taking multiple paths towards mucosal vaccines immunity
5. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits
6. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralisation test in mice for the estimation of tetanus antitoxin in human sera
7. Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826
8. Overview of gut flora and probiotics
9. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit
10. Development of BCG as recombinant vaccine delivery vehicle
11. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing gluthathione S-transferase from Schistosoma haematobium
12. Cleavage of structural proteins during assembly of the head of bacteriophage T4
13. Orally administrated Lactobacillus strains differentially affect the direction and efficacity of the immune response
14. Potential of using lactic acid bacteria for therapy and immunomodulation in man
15. Immunomodulation by treatment with Lactobacillus casei strain Shirota
16. The prophylactic dose of homologous tetanus antitoxin
17. Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: Vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice
18. Development of lactic acid bacteria as live vectors for oral or local vaccines
19. Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen
20. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria
21. Comparative cytokine inducing pattern of lactic acid bacteria used for mucosal vaccine development
22. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C
23. Adhesion of inactivated probiotic strains to intestinal mucus
24. Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: A tool to study in vivo biological effects
25. Immunoglobulin A response in murine schistosomiasis: Stimulatory role of egg antigens
26. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes
27. A simple method of estimating fifty percent endpoints
28. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
29. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain
30. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case
31. Engineering the microflora to vaccinate the mucosa: Serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli
32. Modification of the ELISA for the estimation of tetanus antitoxin in human sera
33. Bacterial vectors: Why have they failed to deliver?
34. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
35. Lactic acid bacteria as vaccine delivery vehicles
36. An overview of gram-positive bacteria as vaccine vehicles for mucosal immunization